UCLA Researchers Secure Prestigious Grant to Tackle Immune Checkpoint Inhibitor Resistance in Melanoma
"While immune checkpoint inhibitors have revolutionized melanoma treatment, a significant portion of patients remain unresponsive, presenting a critical challenge in oncology. This $3.9 million National Cancer Institute grant empowers UCLA…